Literature DB >> 18992712

Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells.

Xiangxuan Zhao1, Yong Liu, Qi Ma, Xiaohui Wang, Haijing Jin, Maryam Mehrpour, Quan Chen.   

Abstract

The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) offers promising therapeutic potential based on its ability to induce apoptosis in various cancer cell lines without obvious adverse effect to normal cells. However, the mechanism of the differential sensitivity towards TRAIL-induced apoptosis remains unclear. Here, we demonstrate that caveolin-1 directly regulated TRAIL-induced apoptosis in HepG2 cells. ShRNA-mediated caveolin knockdown sensitized TRAIL-induced apoptosis and disruption of caveolae structure by the cholesterol-extracting reagent, methyl-beta-cyclodextrin (MCD), enhanced TRAIL-induced apoptosis. Over-expression of caveolin-1 partially blocked TRAIL-induced apoptosis. The engagement of TRAIL with its receptor DR4 reduced the localization of DR4 in caveolae and resulted in its internalization. Blockade of caveolae-mediated internalization of DR4 by filipin III effectively enhanced TRAIL-induced apoptosis. Collectively, our results reveal a new mechanism by which caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992712     DOI: 10.1016/j.bbrc.2008.10.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis.

Authors:  Hong Feng; Ling Guo; Zhiqing Song; Haiqing Gao; Dan Wang; Weisi Fu; Jingyan Han; Zhenyu Li; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.

Authors:  Barbara Testoni; Christine Völlenkle; Francesca Guerrieri; Sabine Gerbal-Chaloin; Giovanni Blandino; Massimo Levrero
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 3.  Caveolin-1: a critical regulator of lung injury.

Authors:  Yang Jin; Seon-Jin Lee; Richard D Minshall; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

4.  HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells.

Authors:  Carmella Romeo; Matthew C Weber; Mahsa Zarei; Danielle DeCicco; Saswati N Chand; Angie D Lobo; Jordan M Winter; Janet A Sawicki; Jonathan N Sachs; Nicole Meisner-Kober; Charles J Yeo; Rajanikanth Vadigepalli; Mark L Tykocinski; Jonathan R Brody
Journal:  Mol Cancer Res       Date:  2016-04-06       Impact factor: 5.852

5.  Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins.

Authors:  Yoshitaka Kawaraguchi; Yousuke T Horikawa; Anne N Murphy; Fiona Murray; Atsushi Miyanohara; Sameh S Ali; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

Review 6.  The therapeutic potential of TRAIL receptor signalling in cancer cells.

Authors:  R Yerbes; C Palacios; A López-Rivas
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

7.  Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer.

Authors:  Yu Tang; Xiangtian Zeng; Fei He; Yonghui Liao; Niansong Qian; Masakazu Toi
Journal:  Med Oncol       Date:  2011-03-17       Impact factor: 3.064

8.  Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.

Authors:  P O Carminati; F S Donaires; M M Marques; E A Donadi; G A S Passos; E T Sakamoto-Hojo
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

9.  Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration.

Authors:  Rafael Mayoral; Ángela M Valverde; Cristina Llorente Izquierdo; Águeda González-Rodríguez; Lisardo Boscá; Paloma Martín-Sanz
Journal:  J Biol Chem       Date:  2009-12-05       Impact factor: 5.157

Review 10.  Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells.

Authors:  Sundas Fayyaz; Ilhan Yaylim; Saime Turan; Sobia Kanwal; Ammad Ahmad Farooqi
Journal:  Mol Biol Rep       Date:  2014-07-19       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.